These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6436553)

  • 1. [An evaluation of antimicrobial removal device to isolate bacteria from bacteremic patients with hematological disorders].
    Nakazawa H; Okamoto S; Murase T; Yoshii Y; Aoki I; Toyama K; Ando Y; Uchida H
    Jpn J Antibiot; 1984 Jul; 37(7):1272-8. PubMed ID: 6436553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antimicrobial removal device. A microbiological and clinical evaluation.
    Wright AJ; Thompson RL; McLimans CA; Wilson WR; Washington JA
    Am J Clin Pathol; 1982 Aug; 78(2):173-7. PubMed ID: 7048940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved recovery of microorganisms from patients receiving antibiotics with the antimicrobial removal device.
    Peterson LR; Shanholtzer CJ; Mohn ML; Gerding DN
    Am J Clin Pathol; 1983 Nov; 80(5):692-6. PubMed ID: 6356871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of the antibiotic removal device for processing blood cultures.
    de Silva MI; Qadri SM; Hood E
    J Natl Med Assoc; 1986 Sep; 78(9):857-61. PubMed ID: 3097333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
    Minami N; Uno N; Shirakawa S; Ohno R; Okumura M; Yamamoto M; Mitomo Y; Hirano M; Shimizu S; Yamada K
    Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an antimicrobial removal device in endophthalmitis cultures.
    Penland RL; Wilhelmus KR
    Retina; 1998; 18(2):169-73. PubMed ID: 9564700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Antibiotic Removal Device.
    Appleman MD; Swinney RS; Heseltine PN
    J Clin Microbiol; 1982 Feb; 15(2):278-81. PubMed ID: 7068823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of new blood culture processing systems.
    Moody JA; Fasching CE; Shanholtzer CJ; Gerding DN; Peterson LR
    J Clin Microbiol; 1984 Sep; 20(3):351-6. PubMed ID: 6386854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the antimicrobial removal device a cost-effective addition to conventional blood cultures?
    Munro R; Collignon PJ; Sorrell TC; Tomlinson P
    J Clin Pathol; 1984 Mar; 37(3):348-51. PubMed ID: 6421896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis.
    Glik J; Kawecki M; Gaździk T; Nowak M
    Pol Przegl Chir; 2012 Jan; 84(1):6-16. PubMed ID: 22472489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased detection of staphylococcal bacteremia using an anti-microbial removal device.
    Carlson LG; Tenover FC; Plorde JJ
    Am J Clin Pathol; 1985 Oct; 84(4):509-12. PubMed ID: 3898813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). III. Secular changes in susceptibility].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Yamaguti O; Ishibashi K; Shigeta S; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Nishikawa M; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Takahashi K; Naito S; Egashira T; Kohno S; Miyazaki Y; Hirakata Y; Aoki S
    Jpn J Antibiot; 2004 Aug; 57(4):311-403. PubMed ID: 15535040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
    Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
    Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the most common pathogenic bacteria in patients with suspected sepsis by multiplex PCR.
    Arabestani MR; Fazzeli H; Nasr Esfahani B
    J Infect Dev Ctries; 2014 Apr; 8(4):461-8. PubMed ID: 24727512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibility].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguchi O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Aug; 59(4):217-315. PubMed ID: 17111595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)].
    Goto H; Takeda H; Kawai S; Watanabe T; Okazaki M; Shimada K; Nakano K; Yokouchi H; Ikemoto H; Mori T; Igari J; Oguri T; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Kudo K; Kobayashi N; Tanaka T; Sumitomo M; Matsushima T; Oka M; Niki Y; Suga M; Tosaka M; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Nasu M; Hiramatsu K; Oikawa S
    Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an Antimicrobial Removal Device (ARD) for detection of septicemia.
    Lundholm M
    Scand J Infect Dis; 1986; 18(5):461-3. PubMed ID: 3535052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.